The Journal of Immunology, Vol 144, Issue 4 1382-1386, Copyright © 1990 by American Association of Immunologists

ARTICLES

Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody

BM Mueller, CA Romerdahl, SD Gillies and RA Reisfeld
Research Institute of Scripps Clinic, La Jolla, CA 92037.

A mouse/human chimeric antibody (ch14.18) was developed that reacts with the disialoganglioside GD2 on the surface of tumor cells of neuroectodermal origin. ch14.18 has the constant regions of a human IgG1 antibody and was expressed in a murine hybridoma. This antibody was produced in tissue culture at concentrations up to 180 mg/liter of spent culture fluid. ch14.18 was characterized and compared to 14.G2a, a murine mAb against GD2 of IgG2a isotype derived from the same parental hybridoma as ch14.18. Scatchard plot analysis of data from saturation binding studies on M21 melanoma cells showed identical binding for ch14.18 and 14.G2a. Indirect immunofluorescence revealed the same staining pattern for ch14.18 and 14.G2a on different melanoma cell lines. Both antibodies were equally capable of targeting M21 xenografts in athymic nude mice. ch14.18- and 14.G2a-activated human C- mediated cytolysis of melanoma cell; however, ch14.18-mediated antibody- dependent cytotoxicity of human effector cells against melanoma cells 50- to 100-fold more efficiently than 14.G2a.

This article has been cited by other articles:

				N. Alvarez-Rueda, S. Leprieur, B. Clemenceau, S. Supiot, V. Sebille-Rivain, A. Faivre-Chauvet, F. Davodeau, F. Paris, J. Barbet, J. Aubry, et al. Binding Activities and Antitumor Properties of a New Mouse/Human Chimeric Antibody Specific for GD2 Ganglioside Antigen Clin. Cancer Res., September 15, 2007; 13(18): 5613s - 5620s. [Abstract] [Full Text] [PDF]

				A. Batova, A. Kamps, S. D. Gillies, R. A. Reisfeld, and A. L. Yu The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro Clin. Cancer Res., December 1, 1999; 5(12): 4259 - 4263. [Abstract] [Full Text] [PDF]

				S. C. Helfand, E. B. Dickerson, K. L. Munson, and M. L. Padilla GD3 Ganglioside Antibody Augments Tumoricidal Capacity of Canine Blood Mononuclear Cells by Induction of Interleukin 12 Cancer Res., July 1, 1999; 59(13): 3119 - 3127. [Abstract] [Full Text] [PDF]

				S. D. Gillies, Y. Lan, J. S. Wesolowski, X. Qian, R. A. Reisfeld, S. Holden, M. Super, and K.-M. Lo Antibody-IL-12 Fusion Proteins Are Effective in SCID Mouse Models of Prostate and Colon Carcinoma Metastases J. Immunol., June 15, 1998; 160(12): 6195 - 6203. [Abstract] [Full Text] [PDF]

				L Goretzki and B. Mueller Receptor-mediated endocytosis of urokinase-type plasminogen activator is regulated by cAMP-dependent protein kinase J. Cell Sci., January 6, 1997; 110(12): 1395 - 1402. [Abstract] [PDF]